<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757549/" ref="ordinalpos=3452&amp;ncbi_uid=2494066&amp;link_uid=PMC2757549" image-link="/pmc/articles/PMC2757549/figure/fig6/" class="imagepopup">Fig. 6. From: OSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt-NF-?B <span class="highlight" style="background-color:">pathway</span> and stress response <span class="highlight" style="background-color:">signaling</span>. </a></div><br /><div class="p4l_captionBody">Diagram depicting the inhibitory and activating effects of OSU-A9 on the Akt–NF-κB signaling axis and stress response signaling, respectively. The ability of OSU-A9 to affect these two signaling networks and thus target different facets of breast malignancy underlies its high potency in suppressing tumor growth.</div></div>